Versican Plus DHPPi/L4R lyophilisate and suspension for suspension for injection for dogs

Safety and efficacy data are available which demonstrate that this vaccine can be
administered with Eurican LR, Eurican L, Eurican Lmulti or Eurican L4 vaccines (used
as solvent) where available.
Safety and efficacy data are available which demonstrate that this vaccine can be
administered on the same day but not mixed with Rabisin if the vaccine has been
reconstituted with Eurican L, Eurican Lmulti or Eurican L4.
When administered with Boehringer Ingelheim's vaccines containing rabies, the
minimum age for vaccination is 12 weeks of age.
When administered reconstituted with the Eurican LR vaccine a small and transient
nodule (maximum size 1.5 cm) at the injection site may be induced due to the presence
of aluminium hydroxide and a slight swelling (~4 cm) may occur after the injection at
injection site, regressing generally within 1-4 days.
When mixed with the Eurican L4 vaccine a swelling (less than 6 cm) may very commonly
occur at the injection site, disappearing within 8 days, anorexia may commonly occur
and vocalisation, tachycardia and tachypnoea may uncommonly be observed. For
Eurican L4, no safety data in pregnant bitches are available for the additional inactivated
strain, Leptospira Australis.
No information is available on the safety and efficacy of this vaccine when used with any
other veterinary medicinal product except the products mentioned above. A decision to
use this vaccine before or after any other veterinary medicinal product therefore needs to
be made on a case by case basis.